Spyre Therapeutics, Inc. (SYRE): 10-Q filed Nov 3, 2026

Form type

10-Q

Filing date

Nov 3, 2026

Accession number

0001636282-26-000131

Filer

Spyre Therapeutics, Inc. (CIK 1636282)